Skip to content
Toggle main navigation
About
About TEPHINET
About TEPHIConnect
Terms of Use and Privacy
How to Join
Why Join?
News
Events
Groups
Journals
BMC Medicine
BMC Medical Research Methodology
Clinical Epidemiology and Global Health
Emerging Microbes & Infections
Frontiers in Epidemiology
Global Health Journal
International Journal of Epidemiology
Online Library Journal
PLoS One
Science Direct Journal (Global Health)
Science Direct Journal (Clinical Epidemiology and Global Health)
More
Open dropdown to see remaining menu items
Log in
Request to join
Erratum: Vol. 71, No. 45
Published on January 19, 2023
Erratum for MMWR Vo. 71, No. 45
Continue reading on website
Other news
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023
January 12, 2023
This report describes similar early safety findings from the Vaccine Adverse Event Reporting System for bivalent booster vaccination in children aged 5-11 years as the monovalent booster vaccination.
EARLY RELEASE: Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Acce...
January 25, 2023
This report describes how a bivalent mRNA booster dose provided additional protection against symptomatic XBB/XBB.1.5 infection for at least the first 3 months after vaccination in persons who had previously received 2-4 monovalent vaccine doses.